N2TP

Drug Discovery

This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.

Autopoiesis

The company develops an artificial intelligence research partner that performs autonomous scientific discovery for researchers at academic institutions and pharmaceutical companies.

CellType

This company develops artificial intelligence agents and biological foundation models to simulate human biology for pharmaceutical and biotechnology drug discovery teams.

Capsule AI

This company develops autonomous agent systems that conduct scientific research and strategic analysis for pharmaceutical and biotechnology organisations.

ScienceMachine

This company develops autonomous artificial intelligence agents to automate biomedical data analysis and research workflows for biotechnology and pharmaceutical organisations.

Kiin Bio

This company develops an artificial intelligence platform of virtual scientists to automate and coordinate drug discovery workflows for biotechnology firms and academic researchers.

Nabla Bio

This company develops generative artificial intelligence and high-throughput screening platforms to design therapeutic antibodies for pharmaceutical and biotechnology partners.

Computational drug discovery platform

This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.